Xiogenix Collaboration Enhances Cellipont's Capabilities

Cellipont Bioservices, a leading CDMO in cell therapy, has partnered with Xiogenix to integrate the Ares™ X20 fill-and-finish system into its offerings. This advanced system automates formulation, ensures precise temperature control, and processes containers efficiently, optimizing manufacturing quality and scalability.

The partnership aims to enhance Cellipont's production capabilities, ensuring high standards in cell therapy development. Darren Head, CEO of Cellipont, and Rachel Bahr, CEO of Xiogenix, both emphasized the collaboration's potential to innovate biopharmaceutical manufacturing and accelerate the delivery of cutting-edge therapies to market.